MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia.

Giovanni MarconiAnnalisa TalamiMaria Chiara AbbenanteChiara SartorSarah ParisiJacopo NanniLuca BertaminiSimone RagainiMatteo OliviStefano de PoloGianluca CristianoMaria Chiara FontanaMaria Teresa BochicchioEmanuela OttavianiMario ArpinatiMariarosaria SessaCarmen BaldazziLucia CasoNicoletta TestoniMichele BaccaraniFrancesca BonifaziGiovanni MartinelliStefania PaoliniMichele CavoCristina PapayannidisAntonio Curti

Published in: European journal of haematology (2020)

WT1 is a useful marker of chemosensitivity after MEC as rescue and bridge-to-transplant therapy.

Keyphrases

acute myeloid leukemia
high dose
disease activity
rheumatoid arthritis
ulcerative colitis
systemic lupus erythematosus
cell therapy
smoking cessation